Correlation Between Okta and Alterity Therapeutics
Can any of the company-specific risk be diversified away by investing in both Okta and Alterity Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Okta and Alterity Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Okta Inc and Alterity Therapeutics, you can compare the effects of market volatilities on Okta and Alterity Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Okta with a short position of Alterity Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Okta and Alterity Therapeutics.
Diversification Opportunities for Okta and Alterity Therapeutics
0.36 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Okta and Alterity is 0.36. Overlapping area represents the amount of risk that can be diversified away by holding Okta Inc and Alterity Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Alterity Therapeutics and Okta is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Okta Inc are associated (or correlated) with Alterity Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Alterity Therapeutics has no effect on the direction of Okta i.e., Okta and Alterity Therapeutics go up and down completely randomly.
Pair Corralation between Okta and Alterity Therapeutics
Given the investment horizon of 90 days Okta Inc is expected to generate 0.65 times more return on investment than Alterity Therapeutics. However, Okta Inc is 1.54 times less risky than Alterity Therapeutics. It trades about 0.13 of its potential returns per unit of risk. Alterity Therapeutics is currently generating about -0.13 per unit of risk. If you would invest 7,325 in Okta Inc on August 29, 2024 and sell it today you would earn a total of 358.00 from holding Okta Inc or generate 4.89% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Okta Inc vs. Alterity Therapeutics
Performance |
| Timeline |
| Okta Inc |
| Alterity Therapeutics |
Okta and Alterity Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Okta and Alterity Therapeutics
The main advantage of trading using opposite Okta and Alterity Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Okta position performs unexpectedly, Alterity Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alterity Therapeutics will offset losses from the drop in Alterity Therapeutics' long position.The idea behind Okta Inc and Alterity Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.| Alterity Therapeutics vs. Eliem Therapeutics | Alterity Therapeutics vs. Scpharmaceuticals | Alterity Therapeutics vs. Milestone Pharmaceuticals | Alterity Therapeutics vs. Seres Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |